S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.06%) $0.926
USD/NOK
(-0.09%) $10.83
USD/GBP
(-0.11%) $0.791
USD/RUB
(-0.21%) $92.38

Realtime updates for Pulmatrix Inc [PULM]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 16:00

7.36% $ 1.750

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302
Profile picture for Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States...

Stats
Today's Volume 38 147.00
Average Volume 16 975.00
Market Cap 6.39M
EPS $-1.030 ( 2023-11-09 )
Next earnings date ( $-1.040 ) 2024-04-04
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.390
ATR14 $0.0220 (1.26%)
Insider Trading
Date Person Action Amount type
2023-01-26 Siegert Michelle Buy 9 900 Stock Option (Right to Buy)
2023-01-26 Wasilewski Margaret Buy 11 400 Stock Option (Right to Buy)
2023-01-26 Raad Teofilo David Buy 34 900 Stock Option (Right to Buy)
2023-01-26 Bazemore Todd Buy 1 700 Stock Option (Right to Buy)
2023-01-26 Higgins Michael J Buy 2 436 Stock Option (Right to Buy)
INSIDER POWER
100.00
Last 94 transactions
Buy: 13 676 591 | Sell: 104 308

Pulmatrix Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pulmatrix Inc Financials

Annual 2023
Revenue: $7.30M
Gross Profit: $7.30M (100.00 %)
EPS: $-3 866.74
Q3 2023
Revenue: $1.75M
Gross Profit: $1.33M (75.70 %)
EPS: $-1.030
Q2 2023
Revenue: $1.84M
Gross Profit: $1.40M (76.14 %)
EPS: $-1.040
Q1 2023
Revenue: $1.50M
Gross Profit: $1.10M (73.25 %)
EPS: $-1.180

Financial Reports:

No articles found.

Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing Pulmazole, an inhaled anti-fungal drug for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma, and in patients with cystic fibrosis; PUR1800, a narrow spectrum kinase inhibitor that is in Phase 1b clinical trials for patients with stable moderate-severe chronic obstructive pulmonary disease; and PUR3100, an iSPERSE formulation of dihydroergotamine for the treatment of acute migraine. The company has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates; a development and commercialization agreement with Cipla Technologies LLC for the development and commercialization of Pulmazole; and a collaboration and license agreement with Sensory Cloud, Inc. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators